...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> Agendia’s MammaPrint® and BluePrint® Tests Highlighted in Multiple Presentations at the 2016 San Antonio Breast Cancer Symposium, Adding Further Clinical Utility
12/02/16
> New Vetter Data Processing Center is Officially Certified
11/30/16
> Orchard Therapeutics Announces Strategic Alliance with Oxford BioMedica
11/29/16
> Orchard Therapeutics and UCLA Receive USD20 Million in Latest Round of Funding from California’s Stem Cell Agency
11/23/16
> RedHill Biopharma Announces YELIVA™ (ABC294640) Poster Presentation at the 2016 EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium
11/21/16
> Independent Clinical Study Shows Adherium’s Smartinhaler™ Dramatically Improves Clinical Outcomes and Medication Adherence in Children with Asthma
11/17/16
> Zytoprotec Phase II Peritoneal Dialysis Study: Last Patient Out
11/14/16
> Prospective Clinical Follow-Up Study with Over 2,200 Patients Confirms High Test Accuracy of Prenatest® for Fetal Trisomies
11/14/16
> Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA Inspection
11/14/16
> RedHill Biopharma Reports Positive FDA Type B Meeting on RHB-105 for H. pylori Infection Ahead of Confirmatory Phase III Study
11/10/16
> Sartorius Stedim Biotech Opens New Bioanalytical Testing Laboratory in Boston
11/10/16
> PSR Orphan Experts Launches Patient Organization Advisory Board
11/08/16
> Agendia’s Proven Breast Cancer Recurrence Assay, MammaPrint, Now Available in the Middle East
11/08/16
> AdAlta Licenses Alzheimer's Disease-Specific Shark Antibodies to Crossbeta Biosciences for Therapeutic and Diagnostic Development
11/08/16
> Changes in the AYOXXA Management Team
11/07/16
> AdAlta and XL-protein Announce Collaboration to Develop a Long Acting Version of Its Lead Fibrosis Drug Candidate AD-114 Using PASylation® Technology
11/07/16
> Mucosis Initiates First-in-Human Study of SynGEM®, a Needle-Free Nasal Spray RSV Vaccine
11/07/16
> Atriva Therapeutics Announces Upcoming US Patent Issuance for MEK Treatment against Viral Diseases
11/04/16
> ARTES and BioSun Announce Co-Development for HPV Vaccine
11/04/16
> RedHill Biopharma Provides Update on Ongoing Phase III and Phase II Studies with BEKINDA® and Expected Timing of Top-Line Results
11/03/16
> NBE Therapeutics Raises CHF 20 Million in Series B Funding
11/03/16
> RedHill Biopharma Announces Proposed Public Offering of its American Depository Shares
11/02/16
> Agendia Announces the Award of a New Category 1 CPT Code from the American Medical Association for the MammaPrint® 70-Gene Breast Cancer Recurrence Assay
11/01/16
> Atomo Diagnostics Receives Grant to Develop New, Innovative HIV Self-Test Solution
10/27/16
> Agendia Expands its Business Activities in Germany
10/26/16
> BioPharmaSpec Appoints Two Senior Technical Staff from the CRO and Biosimilar Fields
10/25/16
> SOTIO and NBE Therapeutics Sign Collaboration and License Agreement for Next-Generation Antibody-Drug Conjugates
10/20/16
> Synaffix Enters into a Commercial License Agreement with ADC Therapeutics
10/20/16
> RedHill Biopharma Announces Allowance of a Patent in Japan Supporting RHB-104 for Multiple Sclerosis
10/18/16
> Agendia Appoints Three Leading Cancer Physicians to Its Medical Advisory Board
10/17/16
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 1 of 45